ESG

A struggling interactive entertainment firm bets its future on gold, targeting Malaysia's booming market. A look at the high-stakes pivot shaking up BHAT.

With a new patent, this biotech targets the massive orthopedics market. But can its novel fibroblast therapy overcome steep financial and clinical hurdles?

Daré Bioscience is targeting a 20M-woman market with a novel arousal cream. This is the story of its clever regulatory strategy and high-stakes bet.

Beyond philanthropy, KinderCare's alumni scholarship is a strategic investment in its brand, building a human capital pipeline from the ground up.

Ontario's new FAST program speeds access to cancer drugs like Scemblix, challenging Canada's slow reimbursement system. Is this a new national blueprint?

A new partnership signals a shift towards versatile, American-made drone systems, streamlining critical missions and challenging market incumbents.

A new partnership between Telix and Varian aims to fuse precision diagnostics with adaptive radiotherapy, a strategic move set to disrupt the cancer care market.

Beyond a simple payout, Amerigo Resources’ latest dividend reveals a powerful strategy of innovation, financial discipline, and a bullish copper market.

As holiday travel chaos looms, one luggage brand is offering free bags to travelers with lost luggage. Is it a marketing masterstroke or a logistical nightmare?

Chemical giant Nouryon is doubling down on Brazil, building a new innovation hub to co-create sustainable beauty and cleaning products for a booming market.

Capital Power unveils a $3B deal with Apollo to buy U.S. gas plants while securing a major deal to power Alberta's AI boom, a bold dual strategy.

As AI transforms software development, a new security blind spot emerges. Discover how one company is tackling threats at the heart of AI-native coding.

Husqvarna unveils a massive cost-cutting plan alongside ambitious growth and green targets. Can this strategic pivot secure its future market leadership?

A Chinese biotech is pioneering next-gen cancer drugs that promise higher precision and fewer side effects. Is this the future of oncology treatment?

Following stellar clinical data, Terns Pharmaceuticals' upsized $650M offering signals massive investor confidence and funds its push to disrupt the CML market.

Major hotel chains are now building integrated living ecosystems for digital nomads. What does this pivot to wellness mean for the future of care?

Bison's Meadowbrook is the first Alberta carbon hub to start operations, a pivotal moment for industrial decarbonization and the province's energy future.

Gossamer Bio's recent 200,000-share grant to a new hire is more than a welcome bonus; it's a strategic bet on its blockbuster drug candidate.

BNY Mellon's steady dividend offers a window into the high-yield debt market, a crucial, high-risk funding source for the mining sector's energy transition.

CEO Amy Perry’s influence is celebrated, but her true test is securing Banner’s vast, AI-driven ecosystem from the escalating threats of the digital age.